Target intelligence / Profile preview

Testis-associated actin remodelling kinase 1 (TESK1)

Target
TESK1
Molecular classification
Enzyme, Serine/threonine kinase, Protein kinase
01

Overview

Testis-associated actin remodelling kinase 1 (TESK1) is a serine/threonine protein kinase with dual specificity, containing an N-terminal kinase domain and a C-terminal proline-rich domain[1][2][3]. It is structurally related to the LIM kinase subclass of kinases. TESK1 was originally identified in the testis and is highly expressed in testicular tissue, but also found at lower levels in other tissues, such as the brain[2][3]. Its primary function is the phosphorylation of cofilin on Serine-3, leading to inactivation of cofilin and thereby promoting actin stress fiber formation and stabilization of the actin cytoskeleton[1][2][3]. TESK1 activity is stimulated by integrin signaling, linking it to extracellular matrix interactions and cell adhesion[1]. It also participates in the regulation of cell spreading and motility and is implicated in various developmental processes. TESK1 interacts with proteins such as Spred1 and Sprouty4, which can inhibit its kinase activity[2]. Disease associations primarily involve male infertility (spermatogenic failure) and possible links to neurodegeneration in model organisms[3][2]. No currently approved drugs are known to selectively target TESK1 in the clinic, and its direct use as a biomarker or drug target is investigational.

Other names
Dual specificity testis-specific protein kinase 1Testicular protein kinase 1Testis-specific kinase 1TESK1
02

Biological functions

Actin cytoskeleton organizationSignal transductionCell spreadingCell adhesionPhosphorylation of cofilinCell migration
03

Disease associations

Spermatogenesis defects (e.g., spermatogenic failure)(Tentative) Neurodegenerative disease (via effects on tau toxicity in Drosophila models)Potential (but not confirmed) roles in cancer and cell motility disorders
04

Safety considerations

No specific safety concerns documented; inhibition may affect cytoskeleton organization and cell adhesion, with possible adverse effects in tissues requiring actin dynamics such as testis and kidney[3][1].

Beyond the preview

Go deeper on Testis-associated actin remodelling kinase 1 (TESK1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testis-associated actin remodelling kinase 1 (TESK1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call